ICON PLC

ICLR

NASDAQ. Currency in USD

183.78 -0.24 ( -0.13% )

Real time prices: September 30

Market Cap.
14.98B
Beta (5Y monthly)
0.99
Price/Earnings
17.69
EPS (TTM)
10.80
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
644,837
1y Target Est.
305.82
Day's Range
183.49
-
191.30
52 Week's Range
179.95
-
313.00

Historical Summary

Performance
EPS growth
Share Buybacks

About ICON PLC

Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.iconplc.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
81.40M
Employees
40500
Address
South County Business Park, Dublin, Ireland, 18
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Latest news

Tracking Ron Baron's BAMCO Portfolio - Q2 2022 Update
Tracking Ron Baron's BAMCO Portfolio - Q2 2022 Update

Ron Baron's 13F portfolio value decreased from $40.75B to $31.14B this quarter. Click here to...
By Seeking Alpha - 4 hours ago

Icon PLC (ICLR) Surges 3%: Is This an Indication of Further Gains?
Icon PLC (ICLR) Surges 3%: Is This an Indication of Further Gains?

Icon PLC (ICLR) witnessed a jump in share price last session on above-average trading volume....
By Zacks Investment Research - 2 weeks ago

What 6 Analyst Ratings Have To Say About Icon
What 6 Analyst Ratings Have To Say About Icon

Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish...
By Benzinga - 2 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022

Upgrades Macquarie upgraded the previous rating for Netflix Inc (NASDAQ:NFLX) from Underperform to Neutral. Netflix...
By Benzinga - 3 weeks ago

Analyst Ratings for Icon
Analyst Ratings for Icon

Analysts have provided the following ratings for Icon (NASDAQ:ICLR) within the last quarter:   Bullish Somewhat...
By Benzinga - 5 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022

Upgrades According to Goldman Sachs, the prior rating for FREYR Battery (NYSE:FREY) was changed from...
By Benzinga - 5 weeks ago

ICLR vs. HQY: Which Stock Should Value Investors Buy Now?
ICLR vs. HQY: Which Stock Should Value Investors Buy Now?

ICLR vs. HQY: Which Stock Is the Better Value Option?
By Zacks Investment Research - 8 weeks ago

Icon PLC (ICLR) Tops Q2 Earnings and Revenue Estimates
Icon PLC (ICLR) Tops Q2 Earnings and Revenue Estimates

Icon PLC (ICLR) delivered earnings and revenue surprises of 2.51% and 0.52%, respectively, for the...
By Zacks Investment Research - 9 weeks ago